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Abstract—Gestational hypertension during the third trimester reflects an exaggerated maternal inflammatory response
to pregnancy. We hypothesized that oxidative stress present even in normal pregnancy becomes uncompensated in
hypertensive patients. A glucose-6-phosphate dehydrogenase (G6PD) activity sufficient to meet the increased reductive
equivalent need of the cells is indispensable for defense against oxidative stress. The erythrocyte glutathione redox
system was studied, where G6PD is the only NADPH source. The glutathione (GSH) redox status was measured both
in vivo and after an in vitro oxidative challenge in pregnant women with gestational hypertension (n 5 19) vs.
normotensive pregnant subjects (n 5 18) and controls (n 5 20). An erythrocyte GSH depletion with an increase in the
oxidized form (GSSG) resulted in an elevated ratio GSSG/GSH (0.305 6 0.057; mean 6 SD) in hypertensive pregnant
women vs. normotensive pregnant or control subjects (0.154 6 0.025; 0.168 6 0.073; p , .001). In hypertensive
pregnant patients, a “GSH stability” decrease after an in vitro oxidative challenge suggested a reduced GSH recycling
capacity resulting from an insufficient NADPH supply. The erythrocyte GSSG/GSH ratio may serve as an early and
sensitive parameter of the oxidative imbalance and a relevant target for future clinical trials to control the effects of
antioxidant treatment in women at increased risk of the pre-eclampsia syndrome. © 2001 Elsevier Science Inc.
Keywords—Oxidized/reduced glutathione, Hemoglobin, Glutathione recycling, Glucose-6-phosphate dehydrogenase,
Free radicals
INTRODUCTION
Hypertensive disorders are relatively common complica-
tions of pregnancy (6–8%) and make a significant con-
tribution to neonatal morbidity and mortality [1]. Gesta-
tional hypertension, a new onset of hypertension
manifested after 20 gestational weeks, without protein-
uria, is currently considered to be the first stage of a
severe multisystem endothelial disorder, the pre-eclamp-
sia syndrome, characterized by an increased blood pres-
sure, proteinuria, and edema [1,2]. Pre-eclampsia is more
than simply hypertension, a consequence of disturbed
placentation with a reduced placental perfusion [3,4].
Hypertension has been explained as a disturbed endothe-
lial control of the vascular tone with an imbalance in the
thromboxane/prostacyclin ratio or an impaired effect of
the vasodilator nitric oxide (NO), which causes maternal
vasodilatation during normal pregnancy [5,6].
In addition to the endothelial dysfunction, a systemic
activation of the maternal inflammatory cell responses
becomes evident in the pre-eclampsia syndrome [7].
Phagocytes (granulocytes and monocytes) produce and
secrete reactive oxygen species as a nonspecific immune
defense mechanism [8,9]. An abnormally activated clot-
ting system and an affected complement system have
been revealed [10], as has an increased release of the
proinflammatory cytokines and fibronectin degradation
products into the circulation [11]. Furthermore, toward
the end of pregnancy, an inflammatory response to preg-
nancy is present even in normal cases [12]. Thus, ac-
cording to a new concept, the clinical symptoms of
pre-eclampsia arise when a universal maternal intravas-
cular inflammatory response to pregnancy decompen-
sates because either the stimulus or the maternal re-
sponse is too strong [7]. Therefore, a generalized
Address correspondence to: Ilona Ne´meth, MD, PhD, Department of
Pediatrics, Albert Szent-Gyo¨rgyi Medical and Pharmaceutical Center,
University of Szeged, Szeged, Hungary, H-6701, POB 471; Tel: 136
(62) 545332/1112; Fax: 136 (62) 545329; E-Mail: nemethil@pedia.
szote.u-szeged.hu.
Free Radical Biology & Medicine, Vol. 30, No. 7, pp. 715–721, 2001
Copyright © 2001 Elsevier Science Inc.
Printed in the USA. All rights reserved
0891-5849/01/$–see front matter
PII S0891-5849(00)00516-5
715
endothelial cell dysfunction is part of a more extensive
inflammatory process [7].
Heterogenous causes have been implicated in the pre-
eclampsia syndrome [13,14]. There are both placental
and maternal factors that predispose to an excessive
maternal inflammatory response syndrome [7]. Placental
hypoxia, as a result of poor placentation, or the maternal
constitution (obesity, hyperlipidemia, and insulin resis-
tance) and pre-existing diseases are factors predisposing
to an excessive maternal response [7]. Recurrence of the
hypertensive disorder in subsequent pregnancies and its
more frequent prevalence in certain families [15] suggest
a genetic predisposition to the exaggerated maternal re-
sponse to pregnancy [7].
There is considerable evidence of an increased free
radical activity both in normal pregnancy and in preg-
nancy-induced hypertension [16–19]. Oxidative stress
was recently postulated as a link in the two-stage model
of pre-eclampsia [20].
Red blood cells (RBCs) containing millimolar con-
centrations of both glutathione (GSH) and hemoglobin
(Hb) circulate in the direct vicinity of the activated
blood cells and the endothelial surface, with a mem-
brane permeable to oxidants. The intracellular GSH
redox system, with a high GSH level and a far lower
concentration of the oxidized form (GSSG), is pre-
dominantly responsible for the protection of both Hb
and the RBC membrane against oxidation and hemo-
lysis. Interrelated enzyme systems function to achieve
the efficient recycling of GSSG to GSH and to provide
the reducing equivalent, NADPH. The activity of the
first and key enzyme of the hexose-monophosphate
shunt (HMP), glucose-6-phosphate dehydrogenase
(G6PD; E.C.1.1.1.49), is indispensable for the defense
against oxidative stress [21].
We hypothesized that the GSH redox system of the
RBCs may be an early and highly sensitive indicator of
oxidative stress. The RBCs are unique targets with which
to assess the sufficiency of G6PD activity because the
RBCs acquire NADPH exclusively from the HMP shunt.
A method of calibrated in vitro oxidative challenge was
evolved by Beutler in order to recognize patients with
defective G6PD activity [22].
The aim of the present study was to assess the redox
status of GSH, the signs of Hb denaturation, and the
GSH recycling capacity of RBCs from patients with
pregnancy-induced hypertension as compared with those
from normotensive pregnants and nonpregnant controls.
The relationships of the ratio GSSG/GSH to the usual
indicators of oxidative stress (the levels of plasma free
thiols, ceruloplasmin, and lipid peroxidation products)
were also established.
MATERIALS AND METHODS
Subjects
Pregnant women with mild hypertension but without
superimposed pre-eclampsia were detected at routine
obstetric visits after 24 weeks of gestation (35.5 6 2.3
weeks; mean 6 SD). In the patients who were included
in the study, an increased blood pressure was measured
for the first time during their present pregnancy. Five of
them had had transient hypertension during a previous
pregnancy. Therefore, they had not been treated either
occasionally or regularly with antihypertensive drugs
before the study. Nineteen subjects (age: 26.3 6 1.2
years; parity: 1.5 6 0.2) met the criterion of gestational
hypertension, defined as an increase of at least 30 mm Hg
in the systolic or 15 mm Hg in the diastolic blood
pressure as compared with the values obtained before 20
weeks of gestation, or an absolute blood pressure of
.140/90 mm Hg if the earlier blood pressure was not
known [1]. Neither proteinuria nor any impairment in
renal function was observed (defined as .500 mg per
24-h urine collection, and plasma creatinine values). The
body weight before pregnancy was 64.2 6 1.7 kg. There
was a .15 kg rise in body weight during pregnancy in 14
patients, with a body weight of 83.7 6 1.5 kg at the time
of the study. Thrombocytopenia, an increased packed
cell volume, and an abnormal liver enzyme activity were
not seen. The patients seemed obese rather than edema-
tous.
Eighteen women with a clinically normal pregnancy,
matched for maternal age (25.3 6 1.3 years), parity
(1.2 6 0.1), and gestational age (35.2 6 1.3 weeks), but
with a significantly lower body weight (69.5 6 1.2 kg;
p , .05) at the time of the study, acted as pregnant
controls. The body weight before pregnancy was 60.5 6
1.4 kg. The control women (65.5 6 1.8 kg, n 5 20) were
normotensive age-matched members of the laboratory
staff, including eight cases with an increased body mass
index. As no inhomogenity was observed in the bio-
chemical data of the control population related to the
body weight was assessed, the data were combined.
This study was previously approved by the Ethical
Committee of the University.
Biochemical analysis of the GSH and Hb redox
systems
Highly sensitive and specific separate determinations
of GSSG and GSH1GSSG concentrations were carried
out by a previously published method [23]. Samples for
GSSG measurement (25 ml of whole blood collected
over EDTA) were hemolyzed within 15 min after veni-
puncture with cold buffer in the presence of N-ethyl-
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maleimide (NEM; final concentration 20 mM in 0.01 M
phosphate buffer containing 5 mM EDTA). The reaction
of NEM with GSH results in the formation of a stable
complex, which prevents its possible oxidation to GSSG.
After incubation with NEM for 60 min at 25°C, meta-
phosphoric acid (final concentration 3%, w/v) was used
to precipitate proteins. The supernatant can be stored at
220°C (max. 6 d) until the spectrophotometric determi-
nation of GSSG. As NEM is an inhibitor of glutathione
reductase, it was separated from the supernatant by gel
filtration with Sephadex G-10 immediately before GSSG
measurement.
For measurement of the total concentration of
GSH1GSSG, 25 ml of whole blood anticoagulated with
EDTA was immediately hemolyzed in 2.5 ml of cold
0.01 M sodium phosphate buffer containing 5 mM
EDTA, pH 5 7.5, and stored at 220°C until spectropho-
tometric analysis (max. 6 d).
The same standard GSH assay mixture was used for
the analysis of GSSG and GSH1GSSG concentrations.
Reagents were dissolved in 0.1 M sodium phosphate/5
mM EDTA buffer, pH 5 7.5; the final volume was 1.0
ml. Components were added in the following sequence:
5,59-dithio-bis-2-nitrobenzoic acid (DTNB) (0.6 mM),
GSSG (0.4 ml of supernatant after NEM removal) or
GSH1GSSG (25 ml of hemolyzate), glutathione reduc-
tase (10 mg), and NADPH (0.2 mM). The combined
actions of DTNB and NADPH in the presence of gluta-
thione reductase result in a reaction cycle, the rate of
which depends on the concentration of GSH1GSSG
recorded at 412 nm during the first 6 min.
GSH (mM) and GSSG (nM) concentrations were cal-
culated by using 5–100 nM GSSG standards and ex-
pressed with reference to Hb determined simultaneously
by the cyanmethemoglobin method.
The “GSH stability test” according to Beutler [22]
was used to measure the recycling capacity of the RBCs
after an in vitro oxidative stress. Acetylphenylhydrazine
(APH) (0.33 mM) was added to the whole blood sample,
together with sufficient glucose. Following incubation at
37°C for 60 min with APH, RBCs deficient in recycling,
but not the normal ones, suffer a marked fall in GSH
level, accompanied by a pronounced Hb oxidation [22].
Concentrations of oxyHb, metHb, and hemichrome were
calculated after absorbance measurements in diluted he-
molyzates at 560, 577, 630, and 700 nm as described by
Winterbourn [24], together with GSH determination be-
fore and after APH incubation.
Other biochemical methods
The proportions of carboxyHb (COHb) and metHb
and the total concentration of Hb in the whole blood
were measured with a Hemoximeter (Radiometer,
Copenhagen, Denmark) within 15 min after venipunc-
ture. The plasma content of the lipid peroxidation prod-
ucts, as fluorescent lipids and conjugated dienes, was
estimated according to Ward et al. [25]. The concentra-
tion of free SH groups in the plasma was measured with
DTNB at 412 nm [26]. Plasma ferroxidase activity was
measured according to Johnson et al. [27]. Ten microli-
ters of plasma was added to the reaction mixture (170 ml
of 1.2 M sodium acetate buffer, pH 6.0; 270 ml of
Chelex100-treated water; 250 ml 1% (w/v) of conalbu-
min solution; and 300 ml of 400 mM Fe(NH4)2(SO4)2
solution. The oxidase activity was measured spectropho-
tometrically by continuous monitoring of Fe(III)-conal-
bumin formation through the absorbance change at 460
nm [27].
Statistical analysis
Clinical data on the patients are reported as means 6
standard deviations (x 6 SD), while results of biochem-
ical analyses are shown in the figures as means 6 stan-
dard errors (x 6 SEM). Statistical analyses included both
parametric (variance analysis, Tukey test and Student’s t
test) and nonparametric tests (Wilcoxon rank test). When
the extent of variance between pairs of groups differed
significantly (p , .05 in the F test), we used the Welch
test (d probe) instead of the t test to compare the mean
values. Correlations between parameters were character-
ized by calculation of the linear regression and correla-
tion coefficients. The significance level for all tests was
taken as a 5 .05.
RESULTS
There was no difference in the whole blood Hb or
COHb concentrations as potential markers of an in-
creased RBC catabolism in the pregnant subjects and the
age-matched control women. However, the concentra-
tion of metHb in the whole blood revealed an increase in
the hypertensive pregnant patients (Table 1).
The GSH level in the normotensive pregnant women
was significantly elevated as compared with that in the
nonpregnant controls (Fig. 1). In contrast, there was a
significantly decreased GSH level in the RBCs from the
pregnant women with a hypertensive disorder, together
with a simultaneously increased GSSG level (Fig. 1).
Elevated ratios of oxidized Hb metabolites (either metHb
or hemichrome) to total Hb from hemolyzates were seen
in both groups of pregnant subjects as compared with the
controls (Fig. 2). In the normotensive pregnant patients,
an increased level of metHb was contrasted by a some-
what elevated metHb and a highly elevated ratio of
hemichrome in the patients with a hypertensive disorder
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(Fig. 2). However, the sum of the two oxidized Hb
metabolites (metHb 1 hemichrome) was significantly
higher in the hypertensive than in the normotensive preg-
nant patients (p , .01).
After an in vitro oxidative stress, a significant fall in
the residual GSH ratio was observed in the hypertensive
pregnant patients as compared either with the controls or
with the normotensive pregnant patients (Fig. 3). How-
ever, the proportions of oxidized derivatives of Hb
(metHb 1 hemichrome) to total Hb after APH were
higher both in the hypertensive pregnant patients and in
the normotensive ones (Fig. 3), suggesting an increased
oxidative susceptibility of Hb from pregnant women in
late pregnancy.
The depletion of erythrocyte GSH and the simulta-
neous increase in GSSG (Fig. 1) resulted in a highly
elevated redox ratio GSSG/GSH in the pregnant subjects
with hypertension as compared either with the controls
or with the normotensive pregnant subjects (Fig. 4). The
concentration of free plasma SH groups displayed a
marked decrease in the hypertensive patients, but also in
the normotensive pregnant women as compared with the
controls (Fig. 4), as a sign of a pro-oxidant state even in
normal late pregnancy.
The erythrocyte GSSG/GSH correlated significantly
with the usual parameters of an oxidative imbalance in
late pregnancy. The plasma level of free thiols (r 5
20.618, n 5 37, p , .01), and the concentration of
fluorescent lipids in the plasma correlated significantly
with the redox ratio (r 5 0.596, n 5 37, p , .01).
Highly significant increases in the ferroxidase activity
of the plasma were seen in both the normotensive and the
hypertensive pregnant patients (Table 1). The activity of
ferroxidase correlated negatively with the level of con-
jugated dienes in the normotensive pregnant subjects
(r 5 20.707, n 5 18, p , .01) but exhibited a weak
positive correlation in the women with hypertensive dis-
orders (r 5 0.456, n 5 19, p , .05).
Table 1. Concentrations of Some Biochemical Parameters in the Plasma and in the Whole Blood of the Study Population (means 6 SD)
Nonpregnant controls
n 5 20
Normotensive pregnants
n 5 18
Hypertensive pregnants
n 5 19
Whole blood values
Total hemoglobin (mM) 8.2 6 0.4 7.8 6 0.6 7.6 6 1.0
Carboxyhemoglobin (mM) 199.5 6 25.1 204.7 6 32.0 229.2 6 38.5
Methemoglobin (mM) 80.5 6 7.4 88.6 6 8.9 128.9 6 6.9*#
Plasma values
Conjugated dienes (OD, 233 nm) 0.52 6 0.26 0.82 6 0.31 1.70 6 0.32*#
Fluorescent lipids (OD, 430 nm) 49.4 6 19.2 68.67 6 28.2 136.8 6 57.4*#
Ceruloplasmin ferroxidase (IU/L) 0.59 6 0.06 1.16 6 0.07*** 1.210 6 0.16***&
*p , .05; ***p , .001 vs. nonpregnant controls; &Welch test used; #p , .05 vs. normotensive pregnants.
Fig. 1. Concentrations of reduced and oxidized glutathione (GSH and
GSSG) in controls and pregnant subjects without/with hypertension
(means 6 SEM). **p , .01; ***p , .001 vs. controls; ##p , .01;
###p , .001 vs. normotensive pregnant subjects.
Fig. 2. Ratio of hemoglobin oxidation products (methemoglobin or
hemichrome) to total hemoglobin in hemolyzates of controls and preg-
nant subjects without/with hypertension. *p , .05; ***p , .001 vs.
controls; #p , .05; ###p , .001 vs. normotensive pregnant subjects.
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DISCUSSION
The clinical status of our patients met the criteria of
mild gestational hypertension without superimposed pre-
eclampsia [1,20]. The results obtained in this study on
the concentrations of thiols in the RBCs and plasma, the
antioxidant activity of ceruloplasmin, and the lipid per-
oxidation parameters confirmed the previous conclusions
that a pro-oxidant status develops in late pregnancy,
which is further enhanced in pregnancy-induced hyper-
tension [16–19,28]. In addition, significant correlations
were found between the usual parameters of an oxidative
imbalance and the erythrocyte GSSG/GSH ratio, our
proposed index.
As a new result, an increased oxidative susceptibility
of Hb to either auto-oxidation or an in vitro oxidative
stress was demonstrated in late pregnancy, even without
a hypertensive disorder. Hb readily undergoes one-elec-
tron oxidation and reduction, and it can act as a source or
sink of free radicals [24]. The oxidation of oxyHb yields
superoxide and metHb, a reversible oxidation product. If
the globin structure is destabilized, metHb can convert to
hemichrome, an irreversible oxidation metabolite, which
has a potential destabilizing effect on the RBC mem-
brane [29]. No direct signs of either Hb denaturation or
RBC membrane destruction were evident in the whole
blood, although the level of free thiols in the plasma was
reduced, as an early sign of a compromised antioxidant
status in the normotensive pregnant subjects.
On the other hand, an increased GSH concentration
with an appropriate (i.e., relatively increased) recycling
capacity was seen as an adaptation to maintain the ade-
quate redox milieu of the RBCs. Enhanced GSH levels
and resistance to oxidation were demonstrated in differ-
ent cells after an oxidant insult mediated by an increased
G6PD expression [30,31]. An efficient level of GSH is
crucial for the maintenance of an adequate metabolism,
antioxidant protection of Hb, and the membrane integrity
of the RBCs. After exhaustion of the antioxidant sys-
tems, the RBCs are the sources of free Hb/heme, which
can inhibit the vasodilator effect of NO [32]. Enhanced
RBC destruction is a frequent complication of mild pre-
eclampsia, even in the absence of overt intravascular
hemolysis [33].
In the hypertensive pregnant patients, we observed
several signs of an uncompensated oxidative stress status
for both the Hb and the GSH redox systems. This was
manifested by a minimally increased metHb concentra-
tion in the whole blood, an elevated level of hemichrome
in the hemolyzate, an increased ratio GSSG/GSH, and a
pronounced GSH fall after in vitro APH loading, with a
simultaneous increase in oxidized Hb derivatives.
The elevated ratio GSSG/GSH in the RBCs from the
hypertensive pregnant subjects was equally due to a
depleted GSH content and a highly elevated GSSG con-
centration. As a new result, a reduced GSH recycling
capacity of the RBCs was demonstrated in the hyperten-
sive pregnant patients, which could be a harmful factor,
predisposing them to oxidative hemolysis. We suggest
that a misadaptation to the normal pregnancy-induced
oxidative stress in hypertensive patients may be a con-
sequence of either a redox-sensitive inactivation of
G6PD, mediated by oxidants from activated neutrophils
[34], or an insufficient induction of the enzyme G6PD
[31].
Fig. 3. Ratio of GSH remaining after in vitro oxidative stress with
acetylphenylhydrazine and ratio of hemoglobin oxidation products
(methemoglobin1hemichrome) to total hemoglobin in hemolyzates of
controls and pregnant subjects without/with hypertension. **p , .01;
***p , .001 vs. controls; ##p , .01; ###p , .001 vs normotensive
pregnant subjects.
Fig. 4. Erythrocyte glutathione redox ratio (GSSG/GSH) and plasma
free thiol concentration in controls and pregnant subjects without/with
hypertension. ***p , .001 vs. controls; ###p , .001 vs. normotensive
pregnant subjects.
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A further possibility for an inadequate adaptation to
the oxidative stress of pregnancy might be a delayed
induction of the 32 kD oxidative stress protein, heme
oxygenase-1 isoform (HOX-1). This enzyme catalyzes
the degradation of endothelial toxic heme to the antiox-
idant biliverdin and the vasodilator carbon monoxide
(CO). CO has been implicated in the control of vascular
tone, akin to NO [35]. HOX-1-derived CO contributed to
the suppression of an acute hypertensive response in vivo
under experimental conditions [36]. In a recent study on
human placentas, an induction of HOX-1 was protective
against cytotoxic damage and promoted the vessel relax-
ation [37]. Furthermore, HOX-1 protein was signifi-
cantly reduced in placentas from pregnancies compli-
cated with pre-eclampsia, as compared with gestationally
matched normal pregnancies [37].
A significant decrease in blood GSH level has previ-
ously been reported in severe forms of pre-eclampsia
complicated with the HELLP syndrome (hemolysis, el-
evated liver enzymes, and low platelet count) [38]. The
RBC glutathione balance has also been measured by
means of NMR in severe states of pre-eclampsia, without
the separate estimation of GSSG [39]. The rate of GSH
oxidation tended to be related to the severity of the
illness and the susceptibility to hemolysis [39]. Our
results in pregnant subjects with mild gestational hyper-
tension provide further evidence on the altered GSH
redox status in an earlier stage of the illness, when the
multisystem disorders are not present, but the normal
vascular adaptations to pregnancy are compromised.
Therefore, we suggest that the erythrocyte ratio
GSSG/GSH may serve as a measurable index of the
oxidative stress status during pregnancy. The ratio may
be a relevant target for future clinical trials to control the
effects of antioxidant treatment in women at increased
risk of the pre-eclampsia syndrome. In a recent study,
Chapell et al. reported the beneficial effect of preventive
vitamin C and E supplementation on the frequency or
recurrence of the pre-eclampsia syndrome [40]. As
ascorbate and GSH provide a cycle for the regeneration
of vitamin E, the main membrane antioxidant in the
RBCs, the ratio GSSG/GSH would presumably be a
useful biochemical indicator to give further evidence of
the effect. Similar studies on patients with severe pre-
eclampsia syndrome are warranted to prove the useful-
ness of the ratio GSSG/GSH as a sensitive parameter of
prognostic value.
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ABBREVATIONS
APH—acetylphenylhydrazine
CO—carbon monoxide
G6PD—glucose-6-phosphate dehydrogenase
GSH—reduced glutathione
GSSG—oxidized glutathione
GSSG/GSH—glutathione redox ratio
Hb—hemoglobin
HMP—hexose-monophosphate shunt
NO—nitric oxide
RBCs—red blood cells
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